Anti-K1 phages were more active in vitro and in vivo against an 0 1 8 :K1 : H7 ColV+ Escherichia coli strain, designated MW, than were other phages. A single intramuscular dose of one anti-K1 phage was more effective than multiple intramuscular doses of tetracycline, ampicillin, chloramphenicol, or trimethoprim plus sulphafurazole in curing mice of a potentially lethal intramuscularly or intracerebrally induced infection of MW; it was at least as effective as multiple intramuscular doses of streptomycin. When MW and the phage were inoculated into different gastrocnemius muscles of the same mice, a rapid reduction in numbers of MW organisms occurred in the MW-inoculated muscle and in other tissues; the numbers of phage particles in the MW-inoculated muscle increased rapidly and greatly. MW failed to proliferate in the brains of intracerebrally infected mice that had been inoculated intramuscularly with the phage at the same time; many more phage particles were found in the brains of these mice than in other sites. The few phage-resistant mutants of MW found in the phage-treated mice were Kl-; previous studies had shown such mutants to be of greatly reduced virulence.
(Received 28 April I98 I ; revised 7 July 1981)
Anti-K1 phages were more active in vitro and in vivo against an 0 1 8 :K1 : H7 ColV+ Escherichia coli strain, designated MW, than were other phages. A single intramuscular dose of one anti-K1 phage was more effective than multiple intramuscular doses of tetracycline, ampicillin, chloramphenicol, or trimethoprim plus sulphafurazole in curing mice of a potentially lethal intramuscularly or intracerebrally induced infection of MW; it was at least as effective as multiple intramuscular doses of streptomycin. When MW and the phage were inoculated into different gastrocnemius muscles of the same mice, a rapid reduction in numbers of MW organisms occurred in the MW-inoculated muscle and in other tissues; the numbers of phage particles in the MW-inoculated muscle increased rapidly and greatly. MW failed to proliferate in the brains of intracerebrally infected mice that had been inoculated intramuscularly with the phage at the same time; many more phage particles were found in the brains of these mice than in other sites. The few phage-resistant mutants of MW found in the phage-treated mice were Kl-; previous studies had shown such mutants to be of greatly reduced virulence.
The phage administered intramuscularly 3-5 d before challenge with a potentially lethal intramuscularly induced infection of MW was protective, the protective effect varying between phage propagated on different bacterial strains.
I N T R O D U C T I O N
The discovery in the 1920s of phages that attack pathogenic bacteria in vitro led to an intensive period of inquiry into their use for treating infectious disease. The earlier claims of success were not substantiated by carefully planned investigations and, hastened by the introduction of antibiotics, investigations into their use for this purpose were largely abandoned. Although phages have occasionally been reported as being effective in treating experimentally produced infections in laboratory animals, much of the success has either been against diseases that do not occur naturally in the test animal, such as Salmonella typhi infection in mice, or under conditions greatly weighted in favour of the phage rather than the infecting bacterium (Wilson & Miles, 1975) . The main reasons postulated for failure of phages to cure infections have been low degree of activity in vivo compared with that in vitro, and the rapid emergence of phage-resistant bacterial mutants. To investigate the validity of these reasons and to obtain more information on the microbial events that follow the introduction of a phage into animals suffering from bacterial infections, studies were carried out on mice that had first been infected with an Escherichia coli strain belonging to a serotype that not uncommonly causes generalized infections in man and animals, and then inoculated with phages. Because of the unexpectedly favourable results obtained in the treatment aspect of these studies, the investigation was extended to compare the efficacy of phages with that of antibiotics in treating both generalized and cerebral infections caused by this strain.
recognized by their ability to lyse K 1+ but not K 1-forms of MW and E. coli K 12.
Bacterial and phage counts. The numbers of bacteria and phage particles in cultures, body fluids and tissues were estimated by a modification of the method of Miles & Misra (1938), using nutrient broth as diluent; tissue samples were first ground with sterile sand in a pestle and mortar or in a Griffith's tube. Bacterial counts were performed on MacConkey agar and phage counts on plates of nutrient agar whose entire surface had been spread with lawns of broth cultures of MW (approximately los viable organisms per plate). Materials for phage assay, except gpleen suspensions, were first held at 58 "C for 30 min; spleen suspensions were not given this treatment because sometimes it reduced their phage titre.
Experimental animals and inoculation procedures. Unsexed White Swiss mice bred at this institute were used when they were 56 d old and weighed approximately 30 g. Intramuscular inoculations of approximately 100 median lethal doses (LD,,) of MW (3 x lo7 viable organisms) were made into the left gastrocnemius muscle; intracerebral inocula comprised approximately 10 x LD,, (500 viable organisms). Unless otherwise stated, phage-treated mice were given 3 x lo8 viable phage particles. Antibiotics, each dose at 25 mg (kg body wt)-', were given to mice as a single dose or as repeated doses at 12 h intervals. Phage and antibiotic inoculations were made into the right gastrocnemius muscle.
R E S U L T S
In vitro activity of phages against M W Of 15 phages that were isolated from specimens of sewage, 9 were identified as anti-K1. The approximate diameter of plaques of the anti-K 1 phages was 1 -5 mm and that of the other phages was 0-5 mm. The anti-K1 phages were much more virulent than the other phages; fewer than 10 viable particles of the anti-K1 phages were required to lyse broth cultures seeded with 3 x los viable organisms of MW, whereas 106-109 viable particles of the other phages were required. MW cultures contained more mutants resistant to the anti-K 1 phages than to the other phages; for example, 50-120 resistant colonies grew within the zone of lysis produced by one drop of undiluted preparations of the anti-K1 phages spotted on a lawn of MW, whereas the number that grew in the case of the other phages was 0-5. The mutants resistant to all the phages were non-lysogenic; those resistant to the anti-Kl phages were K 1-.
Efect of different phages on the numbers of mice dying when infected intramuscularly with MU/
A great difference in mortality was noted between groups of mice that were inoculated with one or other of the 15 phages after they had been infected intramuscularly with MW (Table  1 ). The lowest numbers of deaths were in the groups inoculated with the anti-K1 phages; these included phage R(MW) which had been isolated from the blood of a mouse 24 h after it had been inoculated with MW and 8 h after it had been inoculated with a mixture of all the other phages. Numbers of deaths were usually lower in the groups of mice in which phages were given at the same time as MW than in the groups in which they were given 8 h later. Phages given 16 h after MW had little effect on the course of the disease; by this time, however, all the untreated mice appeared distinctly unwell and by 24 h more than half of them had died. The course of the disease in MW-infected mice given an extract of MW prepared by ultrasonication was similar to that in the untreated ones; this extract was included as a control in this and subsequent experiments because it would be expected to contain much the same bacterial components as the phage preparations.
Inoculation of groups of MW-infected mice intramuscularly or intravenously with 10-fold falling numbers of phage R(K12.K1+) (i.e. phage R that had been propagated on E. coli K 12. K 1+) revealed that low numbers, especially when given intravenously, were sufficient to prevent the mice from dying ( Table 2) . Similar results were obtained when this experiment was repeated.
Eflect of phage R(K12. K l + ) and antibiotics on the numbers of mice dying when infected
intramuscularly or intracerebrally with M W The mortality in groups of mice infected intramuscularly with MW and given one dose of phage R(K12. K1+) 8 h later was significantly lower than that in groups of MW-infected mice that were given instead one or eight doses of tetracycline, ampicillin or chloramphenicol, or of a mixture of equal parts of trimethoprim and sulphafurazole, or one dose of streptomycin; the numbers dying in a group given eight doses of streptomycin were about the same as in the R(K12. Kl+)-treated mice ( Table 3 ). All the deaths occurred within 4 d of infection. The minimum inhibitory concentrations of streptomycin, tetracycline, ampicillin, chloramphenicol, trimethoprim and sulphafurazole for MW were 2.0, 0.8, 1.5, 3.0, 0.8 and 50 pg ml-' respectively. Eleven days after the commencement of the experiment, all 28 surviving mice in the R(K12.K1+)-treated group appeared normal except for 13 that had a macroscopic lesion at the MW-inoculation site; a similar lesion was present in 20 of the 27 surviving mice that had been given eight doses of streptomycin. The mortality in a group of mice infected intracerebrally with MW and then given phage R(K12.Kl') intramuscularly 16 h later was significantly lower than that in groups of mice that were given instead 12 doses of tetracycline, ampicillin, chloramphenicol, or a mixture of trimethoprim and sulphafurazole but not of streptomycin ( Table 4) . Most of the deaths occurred within 4 d of infection. Many of the mice in this experiment exhibited pronounced signs of dysfunction of the central nervous system for several days before they died. Large numbers of MW organisms were isolated from the brain of most of the mice that died, but none or only very low numbers were found in other organs or in the blood. All the isolates of MW from the brain were antibiotic sensitive. When the experiment was terminated at 10 d, 9 of the 14 streptomycin-treated survivors and only 6 of the 19 phage-treated survivors were exhibiting signs of residual brain damage; otherwise all 33 mice appeared healthy. Fate of MW and of phages R(K12.KI+) and 0 in the tissues of mice that had been inoculated intramuscularly or intracerebrally with them Counts were made on the tissues of mice killed at different times after 3 x lo7 viable organisms of MW had been inoculated into one of their gastrocnemius muscles. These revealed that MW multiplied rapidly in the inoculation site and was present there in very high numbers when the animals were near to death -usually 20-28 h after inoculation (Table 5) . Low numbers were present in the uninoculated muscle, blood, spleen, liver and brain of the mice examined 5 min after inoculation. The bacteria were found in increasingly high numbers in the mice killed subsequently; the more severely ill the mouse, the greater were the numbers in its tissues. The numbers in the brain were always comparatively low. phage treatment of E. coli infection 3 13 Five minutes after being inoculated into a gastrocnemius muscle in a dose of 3 x lo8 viable particles, phage R(K12.Kl') was found in fairly high numbers in the blood, spleen, liver, brain and uninoculated gastrocnemius muscle (Table 6 ). They persisted in the blood, liver, uninoculated muscle and brain for a shorter time than they did in the inoculated muscle and, especially, the spleen. Similar results were obtained in mice inoculated with the less virulent non-anti-K1 phage 0 (Table 1) except that this phage persisted for slightly longer in some of the tissues.
In mice inoculated simultaneously with MW into one gastrocnemius muscle and phage R(K 12. K 1+) into the other, the number of MW organisms in the muscle into which they had been inoculated was low in all the mice killed 1 h or more later, much lower than in the muscle of those killed at 5 min ( Table 7) . None of the mice used in this experiment ever appeared unwell. Examination of 10 isolates of MW from the inoculated muscle of each of 31 mice killed 1-48 h after inoculation revealed that only 3 of the 3 10 isolates, one from each of three mice, were phage R resistant; these three isolates were all K1-. MW organisms were not isolated from the blood or spleen of any of the mice killed more than 3 h after inoculation. In the MW-inoculated muscles of the mice examined at 1-20 h, the numbers of R(K12. K1+) particles usually exceeded the numbers of MW organisms by 100-1000 times; phage particles were about 10000-100000 times more numerous than they were in the corresponding site of mice given phage R(K 12. K 1 +) alone (Table 6 ). In this period, too, the numbers of R(K 12. K I+) in the blood and spleen were often about 3-10 times higher than they were in the mice given R(K 12. K 1 +) alone.
In MW-infected mice inoculated with phage 8 h later, the numbers of MW in the MW-inoculated muscle of mice examined 2 h or more after phage administration were usually 10 or more times lower than they were in the mice examined before that time (Table 8) . Ten isolates of MW from the inoculated muscle of each of the 36 mice that were examined between 9 and 168 h after infection were tested for resistance to phage R(K 12. Kl+). Of the 360 isolates, 15 representing 10 mice, were resistant and all of these were K 1-. None of the mice in this experiment died and MW was not isolated from the blood, or spleen, of any of 3 14 * those examined more than 1 h, or 4 or 5 h respectively, after phage administration. Much higher numbers of R(K 12. K 1' ) were found in MW-inoculated muscle, blood and spleen of these mice than were found in the mice that had been given MW and R(K12.Kl') simultaneously (Table 7) or R(K 12. K 1+) alone (Table 6 ); phage particles also persisted longer in the blood than they did in the previous experiments. The experiments with MW and phage R(K12.K1+) ( Tables 7 and 8) were repeated using phage 0 instead of R(K12.K1+). There was little or no reduction in the numbers of MW organisms in the MW-inoculated muscle of the mice that had been inoculated simultaneously with MW and 0. In animals examined at 32-40 h, the time when about half of the remaining mice died in this experiment, the numbers of MW had increased greatly; MW organisms were also present in the blood and spleen of these mice. In the experiment in which phage 0 was given 8 h after MW, all the mice that were not killed for examination died within 32 h; MW organisms were found in very high numbers in the MW-inoculated muscle of all the killed mice and they were also found in the blood and spleen. No MW organisms resistant to phage 0 were isolated from any mice. Only low numbers of phage 0 were found in the MW-inoculated muscle of the mice killed in the early stages of both experiments. Higher numbers were found in the mice killed subsequently, but even then, in the mice treated 8 h after infection, they were never much greater than the numbers of MW organisms also present in the inoculated muscle. Phage particles were also found in the blood and spleen of the mice used in both experiments, but in numbers little higher than those in mice given phage 0 alone.
H . W I L L I A M S S M I T H A N D M . B . H U G G I N S
Increasingly high numbers of organisms were found in the brains of mice examined 3 h or more after they had been inoculated intracerebrally with 500 viable organisms of MW; very high numbers were present in the brains of those examined after 20 h or more (Table 9) . Only low numbers were found in the blood a i d spleen of these mice. Most of the mice in this experiment were very unwell and severely ataxic by 28 h after inoculation; about 50% of them had died by 72 h and 75% of them by 96 h. When mice were given 3 x lo8 viable particles of phage R(K 12. K 1+) into a gastrocnemius muscle at the same time as they were infected intracerebrally with MW, none of them died, and only low numbers of MW were found in their brains and none in their blood and spleens (Table 10 ). Ten isolates of MW from the brain of each of the 36 mice examined between 16 and 168 h after infection were examined for sensitivity to phage R(K 12. K 1+). Of these 360 isolates only 6, representing five mice, were found to be resistant; all six were K1-. The numbers of R(K12 . K l + ) found in the brains of mice examined 12-72 h after infection were much higher than in mice given R(K12.Kl') alone ( Table 6 ). The distribution of R(K12.Kl') in the blood and spleen resembled that in the mice given R(K 12. K 1+) only.
16 H . W I L L I A M S S M I T H A N D M. B . H U G G I N S

Effect of givingphage R(K12 . K l + ) or R ( M W ) to mice before they were challenged with MW
Fewer mice died in groups given phage R(K12.Klt) 1, 2 or 3 d before they were challenged intramuscularly with MW than occurred in similarly challenged groups given an ultrasonicate of E. coli K12.K1+ or sterile broth at these times (Table 11) . When phage R(MW) (i.e. phage R propagated on MW) was used instead of R(K 12. K l+), the protective effect was apparent in mice given phage 5 d before infection as well as in mice given phage 1, 2 or 3 d before infection. The MW extract given 5 d before challenge, however, also provided some protection. Seven of the mice in the group given this treatment died within 2 d of infection, the number increasing to 1 1 by the third day and reaching the final mortality of 12 on the seventh day; all the mice in the corresponding groups given K 12. K 1+ extract or sterile broth had died within 2 d of challenge. Prolonged survival time was also noted in the groups given MW extract 7, 10 or 14 d before infection with MW. The course of the disease in the groups given streptomycin did not differ from that of the corresponding untreated control groups.
When 20 mice that had been inoculated with 3 x lo8 viable particles of R(K12.K1+) 21 d previously were given a similar dose of this phage into the same gastrocnemius muscle and 3 x lo7 viable organisms of MW into the opposite muscle, 15 of them died. When 20 mice were treated identically, except that they were not given the first dose of R(K12.K1+), none showed any signs of ill-health. All of 20 mice that had only been given MW died.
D I S C U S S I O N
The initial aim of this work was to see whether evidence could be produced, by studying the dynamics of phage/bacterium relationships in vivo, to support the commonly held view that the lack of success that has been obtained in using phages to treat bacterial infections is due mainly to reduced phage activity in vivo and to the rapid emergence of phage-resistant bacteria. Phage 0 was only slightly effective in treating infection with E. coli MW because of its low antibacterial activity, noted both in vivo and in vitro. Phage R was in a completely different category. It was highly active in vitro, fewer than 10 viable organisms being sufficient to lyse 10 ml of a broth culture of MW, and this was reflected to a surprisingly high degree in vivo -3 x lo4 phage particles given intramuscularly or 3 x lo3 given intravenously were sufficient to cure mice given a potentially lethal intramuscular dose of MW. Although phage R-resistant mutants are fairly common in cultures, they were found in only a few phage-treated mice, where they were confined to the inoculation site and outnumbered by phage-sensitive organisms. Presumably, they did not complicate therapy because they were K1-: previous studies (Smith & Huggins, 1980) had revealed that K1-mutants of MW are almost completely avirulent for mice. Our findings with phage R, therefore, provide no support for the view that the failure of phage therapy is due to reduced phage activity in vivo and to the rapid emergence of phage-resistant bacteria. Indeed, therapeutic success was due to high in vivo activity and to failure of phage-resistant mutants to proliferate during treatment.
One dose of phage R was at least equivalent to multiple doses of streptomycin, and more effective than multiple doses of tetracycline, ampicillin, chloramphenicol, or trimethoprim plus sulphafurazole in treating mice infected intramuscularly or intracerebrally with MW. The marked superiority of phage R over one dose of streptomycin emphasized its self-perpetuating nature in the presence of susceptible bacteria, a most desirable characteristic for any antibacterial agent. Although these facts need not be taken to imply that phage may still have a role to play in the therapy of bacterial infections, they do suggest that certain aspects of the subject may be worthy of further investigation. The following observations indicate that the curative effect of R was probably due almost entirely to its ability to rapidly destroy MW organisms in the tissues they were infecting: (a) the administration of extracts of E. coli K 12. K 1+, the propagating strain of phage R(K 12. K l+), did not influence the course of the disease produced by intramuscular or intracerebral inoculation of MW; and (b) there was a rapid decrease in the numbers of MW organisms and a coincidental increase in the numbers of phage particles in the tissues of phage R(K 12. K l+)-treated mice, which was more marked than in the tissues of phage 0-treated mice.
The decision to employ preparations of phage R(K12.Kl') instead of phage R(MW) in most experiments was made because they would contain less material of bacterial origin in common with MW than would R(MW). Such material might have influenced the course of the disease produced by MW. The highly beneficial effect observed when a preparation of R(MW) was given to mice 5 d before they were infected with MW was probably due to the MW material it contained, because this effect was not seen when phage R(K 12. K 1+) was given instead of R(MW), and because the extract of MW, but not of K12.K1+, had a beneficial but less marked effect on the course of the disease. This suggests that if phages like R were ever found to be of value in controlling natural outbreaks of disease, it would be advantageous to use pathogenic bacteria for propagating them, provided the resulting preparations were not toxic, rather than to use a non-pathogen like the E. coli K 12. K I + that was used in the present study. It is apparent, though, from the experiment in which R(K 12. K 1 +) failed to cure MW-infected mice that had been inoculated with this phage 2 1 d previously, presumably because the inoculum stimulated phage antibody, that phage antibody could be a complicating factor in phage therapy. 
